Home
Home

Hyperion

Why Hyperion Is Poised to Pull Back

Why Hyperion Is Poised to Pull Back
Motley Fool

Hyperion Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti

Hyperion Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti
Yahoo

Hyperion's Drug Ravicti Likely To Receive FDA Approval

Hyperion's Drug Ravicti Likely To Receive FDA Approval
Seeking Alpha